Clinical trial Recruiting at 1 site Interventional Ages 45 to 56

Comparing mirror therapy, tDCS, and their combination to improve arm movement after stroke

Official title: Comparative Effects of Sensory Augmentation and Neuromodulation on Enhancing Motor Recovery Among Stroke Survivors

Run by Lahore University of Biological and Applied Sciences · NCT07266662 · Data updated 2026-11-12

This study will test whether mirror therapy, transcranial direct current stimulation (tDCS), or both together, added to routine physical therapy, help people aged 45–65 with chronic stroke improve upper-arm movement.

Quick facts

Study typeInterventional
Ages45 Years to 56 Years
SexAll
Enrollment36 (estimated)
SponsorLahore University of Biological and Applied Sciences
Academic / other
Locations2 sites (Lahore, Punjab Province and 1 other locations)
StatusRecruiting
StartedNovember 25, 2025
Main results expectedMay 25, 2026
Study endsMay 30, 2026
Registry record updatedDecember 17, 2025
Trial IDNCT07266662 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 45–65 with chronic (>6 months) ischemic middle cerebral artery stroke, Brunnstrom stage 3 upper-limb impairment, and good compliance are ideal candidates for this protocol.

Probably not a fit

Patients with severe spasticity (Modified Ashworth Scale >3), major cognitive impairment, severe vision or visuospatial neglect, vestibular dysfunction, other neurologic or serious systemic disease, recent recurrent stroke or epilepsy, or upper-extremity orthopedic problems are excluded and unlikely to benefit from these interventions within this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with chronic ischemic middle cerebral artery stroke and persistent upper-extremity impairment will be randomized to receive mirror therapy plus routine physical therapy, tDCS plus routine physical therapy, or a combination of both interventions along with routine physical therapy. Interventions are delivered four times per week for eight weeks at participating sites in Lahore. Motor function and related clinical measures will be recorded before and after the intervention period to compare changes between groups. The trial focuses on Brunnstrom stage 3 patients who are more than six months post-stroke and able to comply with the protocol.

Why it matters

Potential benefit: If successful, the interventions could lead to better upper-limb motor recovery and improved ability to perform daily activities for chronic stroke survivors.

How similar studies have gone: Previous studies have reported modest improvements in upper-limb function from mirror therapy and from tDCS when used separately, but their combined effect remains relatively untested in chronic stroke.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 45-65
* Gender: both male and female
* Ischemic stroke
* Diagnosed cases of middle cerebral artery stroke by neurologist
* Stage of recovery - Chronic (more than 6 months)
* Burnstromm recovery stage 3
* Good Compliance

Exclusion Criteria:

* Vestibular Dysfunction
* Serious cognitive impairment,
* Severe vision or visuospatial neglect
* Spasticity (Modified Ashworth scale \>3)
* Upper extremity contractures
* Upper extremity fractures
* Orthopedic disease
* Neurological conditions (other than stroke)
* Recurrence of stroke or epilepsy during the study period
* Serious systemic impairment or concomitant diseases
* Patients refused to participate in the experiment

Where it's running

  • Pakistan Society of Rehabilitation and Differently Abled Hospital
    Lahore, Punjab Province, Pakistan
    Recruiting
  • Lahore University of Biological and Applied Sciences
    Lahore, Punjab Province, Pakistan
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.